Randomization & Trial Supply Management (RTSM)

Empowering Clinical Trials: Streamlining Randomization and Supply Management with RTSM Solutions

What is RTSM?

RTSM (Randomization and Trial Supply Management) systems enable study teams to manage patient randomization and supply investigational drugs, placebos, and/or medical devices to sites throughout the study lifecycle. RTSM systems are alternatively called Interactive Response Technology (IRT), which encompasses IWRS, IVRS, and IxRS (Interactive Web, Voice, and Voice/Web Response Systems).

These technologies supported site staff in obtaining study kit information, especially when computers were not widely available in surgical rooms. Today, web access is more prevalent in hospital settings, so staff may leverage centralized RTSM systems to manage patients dosages. IxRS is still commonly used throughout the world.

Woman wearing lab coat and gloves looking into microscope
Hands typing on laptop displaying diagram of DNA double helix

Patients must be assigned into different treatment arms via randomization to balance known and unknown subject attributes and demonstrate validity of statistical comparisons. This process is complicated due to Sponsor/CRO requirements such as double blindness (neither patient nor study team knowing which treatment was obtained), complex stratifications, and ability to recruit patients globally while maintaining oversight from a centralized location. With high volumes of subjects, it’s easy to incorrectly assign a randomization number or dispense the wrong treatment kit.

Unlike other clinical systems, such as CTMS and eTMF, that may be managed fully in-house, Sponsors typically rely on IRT vendors to set up studies and provide professional/validation services due to the build complexity.

Key Benefits of RTSM/IRT Systems

Commissioning, qualification, validation icon

Efficient Randomization and Blind Protection

RTSM automates patient enrollment and randomization, reducing human error and bias. It ensures allocation concealment and maintains study blinding. RTSM...

Read More

Efficient Randomization and Blind Protection

RTSM automates patient enrollment and randomization, reducing human error and bias. It ensures allocation concealment and maintains study blinding. RTSM systems have security settings that ensure only a restricted set of users may unblind the patient in case of emergency.

Read Less
Calendar icon

Reduce Trial Delays

Advancements in IRT facilitate adaptive trial design, study start-up, and protocol amendment more quickly than ever. By leveraging pre-built libraries, Sponsors/CROs may shift...

Read More

Reduce Trial Delays

Advancements in IRT facilitate adaptive trial design, study start-up, and protocol amendment more quickly than ever. By leveraging pre-built libraries, Sponsors/CROs may shift away from study-by-study deployment to support mid-study changes. Automation supports cohort management, patient enrollment, drug dispensation, inventory management, and screen failures. With audit trails and user-based access, regulatory compliance is enforced throughout all these processes.

Read Less
Regulatory CMC icon

Optimize Trial Supply Management

Late or damaged shipments can result in patients receiving an unusable product or being disqualified for missing a dose. RTSM technology can not only track unused or...

Read More

Optimize Trial Supply Management

Late or damaged shipments can result in patients receiving an unusable product or being disqualified for missing a dose. RTSM technology can not only track unused or returned drugs during the trial, but it can also be configured to support multiple direct-to-patient shipping scenarios. Resupply can be set predictively or automatically based on actual site enrollment numbers to ensure sites are adequately stocked. Furthermore, you can set system alerts for low depot supply, delayed shipments, and upcoming expiry dates.

Read Less

Important Considerations for RTSM Implementation

Implementation and vendor selection comprise an arduous process, and Sponsors are often unsure what to ask. As novel trial and master protocol designs evolve, the complexity of these decisions will likely grow. For a successful RTSM implementation, consider the following:

  • Study Build Timelines: Sometimes, the core RTSM application will not meet every need of your trial design. Allocate time for the vendor to develop custom programming to incorporate your requirements into the system.
  • Vendor Expertise: Choose an experienced vendor who acts as a partner, understands your study’s unique requirements, and provides expert advice. ProPharma specializes in vendor assessment, guiding your organization through RFX and system demos to select a fit-for-purpose system.
  • Functionality and Flexibility: At a minimum, ensure that the system can accommodate complex protocols, adaptive studies, multiple-subject cohorts, and advanced randomization methods as needed for your drug/therapeutic area.
  • Interoperability: Many clinical trial processes are housed in disparate systems; for example, Sponsors may wish to have the randomization form in EDC and site activation conducted in CTMS. RTSM systems should offer published APIs to integrate with EDC and CTMS.
Two data professionals reviewing data on computer monitor
Two engineers reviewing a small computer device in front of two computer monitors

Popular Vendors in the RTSM/IRT Space

  • EndPoint PULSE: with pre-validated, configurable study components, PULSE streamlines system modifications and simplifies site, user, and supply management.
  • Medidata RTSM: fully pre-validated solution that enables mid-study changes and integrates seamlessly with Rave EDC.
  • Suvoda IRT: offers rich functionality in cohort/stage/phase management, adaptive replacement and randomization, and drug accountability and reconciliation.
  • Veeva RTSM (previously Veracity Logic): modular, quick to configure, and offers features like screening, rescreening, adaptive randomizations, and cohort management.
  • YPrime IRT: provides flexible supply management, Sponsor-controlled cohort management, and easy adjustment of dispensing levels.

ProPharma's RTSM Services & Approach

ProPharma’s R&D Technology team understands the criticality of selecting the right RTSM and excels in aligning your company’s needs with regulations and GxP system best practices. Our comprehensive approach and expert knowledge ensure that your organization is set up for long-term success.

Service Category

How We Can Help

Strategy & Business Process Optimization

  • RTSM System Selection
  • Roadmap Development

Clinical Research Solutions

  • Staff Augmentation

Implementation Support

  • Project Management
  • Configuration & API Integrations (Reporting, EDCs, Datalake)
  • Controlled Document Creation (SOPs, Work Instructions, and Job Aids)
  • User Administration & Training
  • Change Management

Validation

  • Validation Coordination
  • User Acceptance Testing

Managed Services

  • System Administration
  • Release Management
  • System Optimization

RTSM Consulting Expertise

If you want to implement or optimize your RTSM, ProPharma's R&D Technology team comprises experienced consultants who can advise your digital transformation. Contact us to speak with one of our RTSM / IRT experts today.

News & Insights

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

PMA Post-Approval Study Considerations

October 7, 2024

PMA Post-Approval Study Considerations

Learn the essential considerations for conducting Post-Approval Studies (PAS) for medical devices, including protocols, timelines, and reporting requirements to ensure compliance with FDA regulations.

What is a Clinical Evaluation Report (CER)?

September 30, 2024

What is a Clinical Evaluation Report (CER)?

Learn the fundamentals of a Clinical Evaluation Report (CER), its evolution under EU MDR, and strategies for ensuring compliance with medical device regulations.

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Ernst & Young announces Michael Stomberg as a finalized for Entrepreneur Of The Year® 2023 National Award to celebrate ambitious entrepreneurs.

Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

News & Insights

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Previous Post Arrow Next Post Arrow
ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Ernst & Young announces Michael Stomberg as a finalized for Entrepreneur Of The Year® 2023 National Award to celebrate ambitious entrepreneurs.

Previous Award Arrow Next Award Arrow
ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

PMA Post-Approval Study Considerations

October 7, 2024

PMA Post-Approval Study Considerations

Learn the essential considerations for conducting Post-Approval Studies (PAS) for medical devices, including protocols, timelines, and reporting requirements to ensure compliance with FDA regulations.

What is a Clinical Evaluation Report (CER)?

September 30, 2024

What is a Clinical Evaluation Report (CER)?

Learn the fundamentals of a Clinical Evaluation Report (CER), its evolution under EU MDR, and strategies for ensuring compliance with medical device regulations.

Previous Post Arrow Next Post Arrow
Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

Previous Resource Arrow Next Resource Arrow